Literature DB >> 10447689

NMR structure of active and inactive forms of the sterol-dependent antifungal antibiotic bacillomycin L.

L Volpon1, F Besson, J M Lancelin.   

Abstract

The antifungal antibiotic lipopeptide bacillomycin L [cyclo-(L-Asp1-D-Tyr2-D-Asn3-L-Ser4-L-Gln5-D-Ser6++ +-L-Thr7-beta-amino fatty acid)] from Bacillus subtilis belongs to the iturinic family of antifungal agents and acts with a strict sterol-phospholipid dependence on biomembranes. This antibiotic has been analysed using solution NMR spectroscopy in its native active form and its inactive (L-Asp1, D-Tyr2) di-O-methylated form. The structures were calculated under NMR-derived restraints using molecular-dynamic simulated-annealing protocols starting from a random array of atoms. The structure of the native antibiotic is spread over different conformers in which two families are recognized. It was found that most structures have dihedral phi and psi angles defining a type-II' beta-turn including amino acids 5-8, in certain cases stabilized by a 8HN-5CO hydrogen bond, whereas a minority of structures adopt an inverse gamma-turn including amino acids 6-8, stabilized in all cases by an 8HN-6CO hydrogen bond. The di-O-methylation of L-Asp1 and D-Tyr2, an amino acid strictly conserved within the iturinic group of antibiotics, does not induce major differences in the NMR spectra and in the NMR structures. The results are discussed in relation to the specific loss of interaction with sterols when the native antifungal bacillomycin L is methylated on the conserved D-Tyr2 position.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447689     DOI: 10.1046/j.1432-1327.1999.00605.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Evaluation of the toxicity and pathogenicity of biocontrol agents in murine models, chicken embryos and dermal irritation in rabbits.

Authors:  Ocampo-Suarez Iris Betsabee; Sanchez-Salas José Luis; Ragazzo-Sánchez Juan Arturo; Calderón-Santoyo Montserrat
Journal:  Toxicol Res (Camb)       Date:  2016-11-07       Impact factor: 3.524

Review 2.  Ecological and mechanistic insights into the direct and indirect antimicrobial properties of Bacillus subtilis lipopeptides on plant pathogens.

Authors:  J Falardeau; C Wise; L Novitsky; T J Avis
Journal:  J Chem Ecol       Date:  2013-07-16       Impact factor: 2.626

Review 3.  Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.

Authors:  Daniel Balleza; Andrea Alessandrini; Miguel J Beltrán García
Journal:  J Membr Biol       Date:  2019-05-16       Impact factor: 1.843

4.  Cyclodepsipeptides from marine sponges: natural agents for drug research.

Authors:  Gowri Shankar Bagavananthem Andavan; Rosa Lemmens-Gruber
Journal:  Mar Drugs       Date:  2010-03-22       Impact factor: 5.118

Review 5.  Antiviral lead compounds from marine sponges.

Authors:  Sunil Sagar; Mandeep Kaur; Kenneth P Minneman
Journal:  Mar Drugs       Date:  2010-10-11       Impact factor: 5.118

6.  Identification and Characterization of Lipopeptides from Bacillus subtilis B1 Against Sapstain Fungus of Rubberwood Through MALDI-TOF-MS and RT-PCR.

Authors:  K L Sajitha; Suma Arun Dev; E J Maria Florence
Journal:  Curr Microbiol       Date:  2016-03-23       Impact factor: 2.188

7.  An Antimicrobial Metabolite from Bacillus sp.: Significant Activity Against Pathogenic Bacteria Including Multidrug-Resistant Clinical Strains.

Authors:  Ajay G Chalasani; Gunaseelan Dhanarajan; Sushma Nema; Ramkrishna Sen; Utpal Roy
Journal:  Front Microbiol       Date:  2015-12-15       Impact factor: 5.640

8.  Antifungal Activity of Isolated Bacillus amyloliquefaciens SYBC H47 for the Biocontrol of Peach Gummosis.

Authors:  Xunhang Li; Yanzhou Zhang; Zhiwen Wei; Zhengbing Guan; Yujie Cai; Xiangru Liao
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

9.  Characterizing the anti-HIV activity of papuamide A.

Authors:  Cynthia D Andjelic; Vicente Planelles; Louis R Barrows
Journal:  Mar Drugs       Date:  2008-10-08       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.